SA
HCM logo
HUTCHMED (China) Limited(HCM)
Closing price · checked 8:25 PM ETAbout this dataData status
$13.22▼-0.23 (-1.71%)
Extended:$13.22+0.00 (+0.00%)· 8:25 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

HUTCHMED (China) Limited (HCM)

EBITDA Margin

-3.74%

TTM · Period ending:

HCM logo

HCM EBITDA Margin

Latest reported-3.74%
HCM EBITDA Margin (-29.93% → -3.74%)
Powered by
High-resolution chart · PNG

What is ebitda margin?

EBITDA as a percentage of revenue.

HCM ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it, in percentage points.

HUTCHMED (China) Limited EBITDA Margin — Annual fiscal periods
Period endingEBITDA MarginChange
-7.5309%−2.55 pts
-4.9768%−8.15 pts
3.1721%+85.57 pts
-82.3981%−41.03 pts
-41.373%+42.94 pts
-84.3178%−18.36 pts
-65.9539%−27.63 pts
-38.3244%−17.80 pts
-20.5234%−0.46 pts
-20.0658%−15.71 pts
-4.3523%+15.08 pts
-19.4297%−45.64 pts
26.2062%−36.69 pts
62.8962%+56.04 pts
6.8582%+5.09 pts
1.7635%+1.81 pts
-0.0422%+10.97 pts
-11.0105%−1.91 pts
-9.0965%−4.11 pts
-4.9868%+4.04 pts
-9.024%+20.90 pts
-29.928%—

Frequently asked questions: HCM ebitda margin

What is HUTCHMED (China) Limited (HCM)'s current ebitda margin?

HUTCHMED (China) Limited (HCM)'s latest reported ebitda margin (TTM) is -3.74% as of Jun 30, 2026. EBITDA as a percentage of revenue.

How much historical ebitda margin data is available for HCM?

Stock Alarm Pro provides 22 dated annual fiscal periods observations for HUTCHMED (China) Limited (HCM)'s ebitda margin, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare HCM's ebitda margin to peers or set an alert?

You can open HCM's ebitda margin in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on HCM delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.